Literature DB >> 28035112

The incidence of Borrelia burgdorferi, Anaplasma phagocytophilum and Babesia microti coinfections among foresters and farmers in eastern Poland.

Anna Pañczuk1, Małgorzata Tokarska-Rodak1, Maria Kozioł-Montewka1, Dorota Plewik2.   

Abstract

BACKGROUND &
OBJECTIVES: Lyme borreliosis is the most common tick-borne disease in Europe and the USA. However, a great variety of pathogens are transmitted by ticks, which results in mixed infections, with Lyme borreliosis. The aim of the present study was to show the incidence of Borrelia burgdorferi, Anaplasma phagocytophilum, and Babesia microti coinfections among the population of foresters and farmers, as these people, due to their profession, are particularly exposed to tick contact.
METHODS: The study was carried out in eastern Poland (the northern part of the Lublin Province) in 2013. The study was performed in a group of 93 individuals occupationally exposed to tick bites (foresters and farmers), whose blood serum showed the presence of IgG anti-B. burgdorferi antibodies. Blood serum in this group were evaluated for IgG anti-A. phagocytophilum and IgG anti-B. microti antibodies by means of IFA IgG indirect immunofluorescence tests. Information related to age, sex, number of tick bite episodes, presence of various symptoms related to the tick bites, and antibiotic therapy applied as treatment for diagnosed Lyme borreliosis were obtained from the subjects through a structured questionnaire. The results were analyzed in Statistica v. 7.1 statistical analysis software.
RESULTS: The presence of IgG antibodies against the analyzed pathogens revealed B. burgdorferi and A. phagocytophilum coinfection in 26 (28%) of the examined subjects and B. burgdorferi and B. microti coinfection in one person (1.1%). No coinfection with all the three pathogens was observed in any individual. The co-occurrence of headache plus bone, joint and muscle pain was noted significantly more often among individuals diagnosed with B. burgdorferi and A. phagocytophilum coinfection. INTERPRETATION &
CONCLUSION: Foresters and farmers are exposed to B. burgdorferi and A. phagocytophilum coinfection in the study area. Therefore, it is probable that these pathogens may severely interfere with the clinical course of Lyme borreliosis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28035112

Source DB:  PubMed          Journal:  J Vector Borne Dis        ISSN: 0972-9062            Impact factor:   1.688


  5 in total

1.  Some aspects on tick species in Mongolia and their potential role in the transmission of equine piroplasms, Anaplasma phagocytophilum and Borrelia burgdorferi L.

Authors:  Myadagsuren Narankhajid; Chultemsuren Yeruult; Agvaandaram Gurbadam; Jigjav Battsetseg; Stephan W Aberle; Badamdorj Bayartogtokh; Anja Joachim; Georg Gerhard Duscher
Journal:  Parasitol Res       Date:  2018-09-03       Impact factor: 2.289

2.  Global meta-analysis on Babesia infections in human population: prevalence, distribution and species diversity.

Authors:  Solomon Ngutor Karshima; Magdalene Nguvan Karshima; Musa Isiyaku Ahmed
Journal:  Pathog Glob Health       Date:  2021-11-17       Impact factor: 3.735

3.  Prevalence of Anaplasma phagocytophilum in Ixodes ricinus and Dermacentor reticulatus and Coinfection with Borrelia burgdorferi and Tick-Borne Encephalitis Virus in Western Ukraine.

Authors:  Iryna Ben; Ihor Lozynskyi
Journal:  Vector Borne Zoonotic Dis       Date:  2019-06-18       Impact factor: 2.133

4.  Tick magnets: The occupational risk of tick-borne disease exposure in forestry workers in New York.

Authors:  Amanda Roome; Sugam Gouli; Ratdanai Yodsuwan; Jennifer Victory; Casie Collins; Paul Jenkins; Melissa Scribani; Nicole Krupa; Daniel Freilich; Anne Gadomski
Journal:  Health Sci Rep       Date:  2022-02-23

5.  Pathogenesis of Borrelia burgdorferi and Babesia microti in TLR4-Competent and TLR4-dysfunctional C3H mice.

Authors:  Lavoisier Akoolo; Vitomir Djokic; Sandra C Rocha; Nikhat Parveen
Journal:  Cell Microbiol       Date:  2021-06-09       Impact factor: 3.715

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.